Crossmark

Prognostic signature and therapeutic drug identification for dilated cardiomyopathy based on necroptosis via bioinformatics and experimental validation

Crossref DOI link: https://doi.org/10.1038/s41598-024-83455-8

Published Online: 2025-01-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Han

Wang, Zhenwei

Xu, Yawei

Du, Yimei

Yang, Haibo

Lu, Yang
Funding

Funding for this research was provided by:

the National Natural Science Foundation of China (82170326, 82300395)
License Information

Text and Data Mining valid from 2025-01-02

Version of Record valid from 2025-01-02
More Information

Article History

Received: 31 July 2024

Accepted: 16 December 2024

First Online: 2 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below